Literature DB >> 33391880

Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia.

Hendra Wibawa1, Mohamad Saifudin Hakim2, Edwin Widyanto Daniwijaya3, Ludhang Pradipta Rizki2, Endah Supriyati4, Dwi Aris Agung Nugrahaningsih5, Kristy Iskandar6, Nungki Anggorowati7, Alvin Santoso Kalim8, Dyah Ayu Puspitarani8, Kemala Athollah8, Eggi Arguni9, Titik Nuryastuti2, Tri Wibawa2.   

Abstract

BACKGROUND: Recently, SARS-CoV-2 virus with the D614G mutation has become a public concern due to rapid dissemination of this variant across many countries. Our study aims were (1) to report full-length genome sequences of SARS-CoV-2 collected from four COVID-19 patients in the Special Region of Yogyakarta and Central Java provinces, Indonesia; (2) to compare the clade distribution of full-length genome sequences from Indonesia (n = 60) from March to September 2020 and (3) to perform phylogenetic analysis of SARS-CoV-2 complete genomes from different countries, including Indonesia.
METHODS: Whole genome sequencing (WGS) was performed using next-generation sequencing (NGS) applied in the Illumina MiSeq instrument. Full-length virus genomes were annotated using the reference genome of hCoV-19/Wuhan/Hu-1/2019 (NC_045512.2) and then visualized in UGENE v. 1.30. For phylogenetic analysis, a dataset of 88 available SARS-CoV-2 complete genomes from different countries, including Indonesia, was retrieved from GISAID.
RESULTS: All patients were hospitalized with various severities of COVID-19. Phylogenetic analysis revealed that one and three virus samples belong to clade L and GH. These three clade GH virus samples (EPI_ISL_525492, EPI_ISL_516800 and EPI_ISL_516829) were not only located in a cluster with SARS-CoV-2 genomes from Asia but also those from Europe, whereas the clade L virus sample (EPI_ISL_516806) was located amongst SARS-CoV-2 genomes from Asia. Using full-length sequences available in the GISAID EpiCoV Database, 39 of 60 SARS-CoV-2 (65%) from Indonesia harbor the D614G mutation.
CONCLUSION: These findings indicate that SARS-CoV-2 with the D614G mutation appears to become the major circulating virus in Indonesia, concurrent with the COVID-19 situation worldwide.
© 2020 Gunadi et al.

Entities:  

Keywords:  COVID-19; D614G mutation; Indonesia; Phylogenetic analysis; SARS-CoV-2; Whole genome sequencing

Year:  2020        PMID: 33391880      PMCID: PMC7759132          DOI: 10.7717/peerj.10575

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  11 in total

1.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

Authors:  Sudhir Kumar; Glen Stecher; Michael Li; Christina Knyaz; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

2.  The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.

Authors:  Alexandra L Phelan; Rebecca Katz; Lawrence O Gostin
Journal:  JAMA       Date:  2020-02-25       Impact factor: 56.272

3.  A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways.

Authors:  Ramon Lorenzo-Redondo; Hannah H Nam; Scott C Roberts; Lacy M Simons; Lawrence J Jennings; Chao Qi; Chad J Achenbach; Alan R Hauser; Michael G Ison; Judd F Hultquist; Egon A Ozer
Journal:  EBioMedicine       Date:  2020-11-11       Impact factor: 8.143

4.  SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.

Authors:  Yixuan J Hou; Shiho Chiba; Peter Halfmann; Camille Ehre; Makoto Kuroda; Kenneth H Dinnon; Sarah R Leist; Alexandra Schäfer; Noriko Nakajima; Kenta Takahashi; Rhianna E Lee; Teresa M Mascenik; Rachel Graham; Caitlin E Edwards; Longping V Tse; Kenichi Okuda; Alena J Markmann; Luther Bartelt; Aravinda de Silva; David M Margolis; Richard C Boucher; Scott H Randell; Tadaki Suzuki; Lisa E Gralinski; Yoshihiro Kawaoka; Ralph S Baric
Journal:  Science       Date:  2020-11-12       Impact factor: 47.728

5.  Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread.

Authors:  Adam Brufsky
Journal:  J Med Virol       Date:  2020-06-24       Impact factor: 20.693

6.  Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.

Authors:  Tam Thi Nguyen; Thach Ngoc Pham; Trang Dinh Van; Trang Thu Nguyen; Diep Thi Ngoc Nguyen; Hoa Nguyen Minh Le; John-Sebastian Eden; Rebecca J Rockett; Thuong Thi Hong Nguyen; Bich Thi Ngoc Vu; Giang Van Tran; Tan Van Le; Dominic E Dwyer; H Rogier van Doorn
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

7.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

8.  A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.

Authors:  Bethany Dearlove; Eric Lewitus; Hongjun Bai; Yifan Li; Daniel B Reeves; M Gordon Joyce; Paul T Scott; Mihret F Amare; Sandhya Vasan; Nelson L Michael; Kayvon Modjarrad; Morgane Rolland
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 12.779

View more
  10 in total

1.  Tracking the molecular evolution and transmission patterns of SARS-CoV-2 lineage B.1.466.2 in Indonesia based on genomic surveillance data.

Authors:  Mingjian Zhu; Qianli Zeng; Bryanna Infinita Laviashna Saputro; Sien Ping Chew; Ian Chew; Holie Frendy; Joanna Weihui Tan; Lanjuan Li
Journal:  Virol J       Date:  2022-06-16       Impact factor: 5.913

2.  Emergency high ligation in a suspected COVID-19 pediatric patient with incarcerated inguinal hernia: A case report.

Authors:  Munawir Makkadafi; Aditya Rifqi Fauzi; Amsyar Praja; Kemala Athollah
Journal:  Ann Med Surg (Lond)       Date:  2021-01-25

3.  Evolutionary dynamics of SARS-CoV-2 circulating in Yogyakarta and Central Java, Indonesia: sequence analysis covering furin cleavage site (FCS) region of the spike protein.

Authors:  Nastiti Wijayanti; Faris Muhammad Gazali; Endah Supriyati; Mohamad Saifudin Hakim; Eggi Arguni; Marselinus Edwin Widyanto Daniwijaya; Titik Nuryastuti; Matin Nuhamunada; Rahma Nabilla; Sofia Mubarika Haryana; Tri Wibawa
Journal:  Int Microbiol       Date:  2022-02-14       Impact factor: 3.097

4.  Detection of SARS-CoV-2 spike protein D614G mutation by qPCR-HRM analysis.

Authors:  Faris Muhammad Gazali; Matin Nuhamunada; Rahma Nabilla; Endah Supriyati; Mohamad Saifudin Hakim; Eggi Arguni; Edwin Widyanto Daniwijaya; Titik Nuryastuti; Sofia Mubarika Haryana; Tri Wibawa; Nastiti Wijayanti
Journal:  Heliyon       Date:  2021-09-06

5.  Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021.

Authors:  Reviany V Nidom; Setyarina Indrasari; Irine Normalina; Astria N Nidom; Balqis Afifah; Lestari Dewi; Andra K Putra; Arif N M Ansori; Muhammad K J Kusala; Mohammad Y Alamudi; Chairul A Nidom
Journal:  Bull Natl Res Cent       Date:  2021-11-21

Review 6.  COVID-19 in Southeast Asia: current status and perspectives.

Authors:  Dinh-Toi Chu; Suong-Mai Vu Ngoc; Hue Vu Thi; Yen-Vy Nguyen Thi; Thuy-Tien Ho; Van-Thuan Hoang; Vijai Singh; Jaffar A Al-Tawfiq
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

7.  A Comparison of Bioinformatics Pipelines for Enrichment Illumina Next Generation Sequencing Systems in Detecting SARS-CoV-2 Virus Strains.

Authors:  Stefanus Bernard; Hendra Wibawa; Mohamad Saifudin Hakim; Arli Aditya Parikesit; Chandra Kusuma Dewa; Yasubumi Sakakibara
Journal:  Genes (Basel)       Date:  2022-07-26       Impact factor: 4.141

8.  Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.

Authors:  Hendra Wibawa; Mohamad Saifudin Hakim; Ika Trisnawati; Riat El Khair; Rina Triasih; Kristy Iskandar; Nungki Anggorowati; Edwin Widyanto Daniwijaya; Endah Supriyati; Dwi Aris Agung Nugrahaningsih; Eko Budiono; Heni Retnowulan; Yunika Puspadewi; Ira Puspitawati; Osman Sianipar; Dwiki Afandy; Susan Simanjaya; William Widitjiarso; Dyah Ayu Puspitarani; Fadil Fahri; Untung Riawan; Aditya Rifqi Fauzi; Alvin Santoso Kalim; Nur Rahmi Ananda; Amalia Setyati; Dwikisworo Setyowireni; Ida Safitri Laksanawati; Eggi Arguni; Titik Nuryastuti; Tri Wibawa
Journal:  BMC Med Genomics       Date:  2021-06-01       Impact factor: 3.063

9.  Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations.

Authors:  Mohamad Saifudin Hakim; Hendra Wibawa; Ika Trisnawati; Endah Supriyati; Riat El Khair; Kristy Iskandar; Nungki Anggorowati; Edwin Widyanto Daniwijaya; Dwi Aris Agung Nugrahaningsih; Yunika Puspadewi; Susan Simanjaya; Dyah Ayu Puspitarani; Hana Fauzyyah Hanifin; Alvina Alexandra Setiawan; Irene Tania; Cita Shafira Amalia; I Putu Aditio Artayasa; Haries Rachman; Herdiyanto Mulyawan; Nur Rahmi Ananda; Eggi Arguni; Titik Nuryastuti; Tri Wibawa
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

10.  Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?

Authors:  Mohamad Saifudin Hakim; Hendra Wibawa; Vivi Setiawaty; Ika Trisnawati; Endah Supriyati; Riat El Khair; Kristy Iskandar; Nungki Anggorowati; Edwin Widyanto Daniwijaya; Dwi Aris Agung Nugrahaningsih; Yunika Puspadewi; Dyah Ayu Puspitarani; Irene Tania; Khanza Adzkia Vujira; Muhammad Buston Ardlyamustaqim; Gita Christy Gabriela; Laudria Stella Eryvinka; Bunga Citta Nirmala; Esensi Tarian Geometri; Abirafdi Amajida Darutama; Anisa Adityarini Kuswandani; Sri Handayani Irianingsih; Siti Khoiriyah; Ina Lestari; Nur Rahmi Ananda; Eggi Arguni; Titik Nuryastuti; Tri Wibawa
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.